# Inopak Ltd – FDA Inspection, Mar 24, 2017

Source: https://www.keypedia.com/records/fda_inspections/inopak-ltd/61aa82b7-8d34-4508-ae28-371152013f7a
Source feed: FDA_Inspections

> FDA inspection 1010061 of Inopak Ltd, March 24, 2017. Classification: Voluntary Action Indicated (VAI). 8 citations under 21 CFR part 211. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1010061
- Company Name: Inopak Ltd
- Inspection Date: 2017-03-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 8

## Related Documents

- [FDA Inspection 1214661 - 2023-08-03](https://www.keypedia.com/records/fda_inspections/inopak-ltd/224adfbd-9afe-4994-83d4-6cc6410b606a)
- [FDA Inspection 1144199 - 2021-06-18](https://www.keypedia.com/records/fda_inspections/inopak-ltd/57c49b30-8d0c-4e9b-aa36-7303934a6506)
- [FDA Inspection 1059942 - 2018-07-20](https://www.keypedia.com/records/fda_inspections/inopak-ltd/c0307baa-4e31-4b91-871b-468b8719c9fe)
- [FDA Inspection 913858 - 2015-02-11](https://www.keypedia.com/records/fda_inspections/inopak-ltd/335a4e40-2af1-417e-a921-3f4a3ba718a7)
- FDA Inspection 797562 - 2012-09-11

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/nancy-f-scheraga/7ab7500d-901f-4953-95a7-4a2b22488f04)

Company: https://www.keypedia.com/companies/inopak-ltd/0e7c501d-9636-4cc2-b8dc-f2a1cb0c3f44

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
